Navigation Links
Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry
Date:12/1/2009

INDIANAPOLIS, Dec. 1 /PRNewswire-FirstCall/ -- The educational resource, "The Value of Medicine, Improving Health... Improving Life," created by Lilly USA (NYSE: LLY), is now available at www.lillyforbetterhealth.com/value_of_medicine.jsp. The booklet supports Lilly's commitment to providing "Answers That Matter" and encourages an open dialogue with patients, providers, payers and the public about pharmaceutical industry practices.

"Today, Lilly and others in health care face tough questions about access to care, managing costs, drug safety and the best ways to fight disease," said David Ricks, president, Lilly USA. "Providing answers requires that we understand diverse perspectives, offer reliable information and keep the focus on what's best for patients. This booklet was created to build understanding between Lilly and its partners in the health care system as we pursue a shared goal of improving health outcomes for patients."

This is the fourth edition of the resource, which covers topics including(1):

  • Medicine spending - Prescription medicines account for only 10 cents of every dollar spent on health care.(2) In fact, many prescription medicines help reduce other health care costs.(3)
  • Access - Pharmaceutical companies are committed to making medicines accessible to patients in financial need. Through patient assistance programs in the United States, the industry provided medicines worth an estimated $14.5 billion and filled more than 115 million prescriptions for patients in need between 2005 and 2008.(4)
  • Importation - Purchasing medicines from other countries is illegal, risky and unsafe,(5) and does not guarantee a cost savings for consumers.(6)
  • Value of medicine - Advances in medicine have helped to increase longevity.(7) Medicines can lower overall treatment costs and help people avoid the disability and death caused by disease.(8)
  • Importance of innovation - Pharmaceutical companies invest more in research and development than other industries.(9) The vast majority of new medicines are discovered and developed by the pharmaceutical industry, not the government.(10)
  • Marketing - The pharmaceutical industry spends much more searching for new medicines than it does on promoting those medicines already on the market.(11,12) Research indicates that direct-to-consumer advertisements encourage dialogue between patients and health care providers, prompting many Americans to discuss their illnesses with health care providers for the first time or to do so earlier than they otherwise would have.(13)

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

CR-LLY

(1) The Value of Medicine, Improving Health...Improving Life: Data on file, Lilly USA, LLC, MG59303.

(2) Department of Health and Human Services, Centers for Medicare and Medicaid Services. 2007 National Health Expenditure data. Available at: http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. Accessed May 14, 2009.

(3) Insurance Journal. Study: High Prescription Drug Costs Help Lower Other Medical Costs. Available at: http://www.insurancejournal.com/news/national/2008/05/22/90245.htm. Accessed November 19, 2009.

(4) PhRMA Annual Survey: PhRMA Member Company Patient Assistance Programs: Data on file, Lilly USA, LLC, B2B20090701B.

(5) Centers for Disease Control. Counterfeit Drugs and Travel. Available at: http://wwwnc.cdc.gov/travel/content/counterfeit-drugs.aspx. Accessed November 19, 2009.

(6) Consumeraffairs.com. Report: Importing Drugs Wouldn't Save Money. Available at http://www.consumeraffairs.com/news04/rx_reimport_report.html. Accessed November 10, 2009.

(7) Lichtenberg FR. The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001. NBER Working Paper No. 9754. Cambridge, MA: National Bureau of Economic Research; June 2003.

(8) Medtap International. The Value of Investment in Health Care: Better Care, Better Lives. Available at:

http://www.aha.org/aha/research-and-trends/AHA-policy-research/VoIHC-more-resources.html. Accessed November 19, 2009.

(9) R&D Ratios & Budgets. Libertyville, IL: Schonfeld & Associates, Inc.; June 2008.

(10) Department of Health and Human Services. NIH Response to the Conference Report Request for a Plan to Ensure Taxpayers' Interests are Protected. Available at: http://www.nih.gov/news/070101wyden.htm. Accessed November 19, 2009.

(11) IMS Health, IMS Integrated Promotional Services, June 2009: Data on file, Lilly USA, LLC, B2B20090701E.

(12) Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2009. Washington, D.C.: PhRMA; March 2009.

(13) The U.S. Food and Drug Administration. The Impact of Direct-To-Consumer

Advertising. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143562.htm. Accessed November 19, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Surpasses United Way 2009 Campaign Goal
2. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
3. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
4. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
5. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
6. Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
7. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
8. Lilly Declares Fourth-Quarter Dividend
9. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
10. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
11. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... combining seaweeds, botanicals and 100 percent pure essential oils, announced the company had a ... Head, SC. , The annual ECRM event gives companies that work in the nutritional, ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true ... mother of three in Oklahoma City, and a devoted woman of faith. , “Becoming ... been in the back of my mind for years, but actually doing it might have ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
Breaking Medicine News(10 mins):